Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.52 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 7/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | APEX1 | P27695 | 1/20 | 0.33 |
| ▸ | PI4KA | P42356 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11096840 | 0.95 | HPGD (0.53) | LMNAHPGDESR1MAPTALDH1A1 | |
| SCHEMBL11436751 | 0.84 | HPGD (0.52) | LMNAHPGDESR1MAPTALDH1A1 | |
| SCHEMBL11096886 | 0.84 | HPGD (0.56) | LMNAHPGDESR1MAPTALDH1A1 | |
| SCHEMBL27244485 | 0.84 | ALDH1A1 (0.57) | LMNAHPGDESR1MAPTALDH1A1 | |
| SCHEMBL9097192 | 0.82 | LMNA (0.55) | LMNAHPGDESR1MAPTALDH1A1 | |
| SCHEMBL9839604 | 0.82 | ALDH1A1 (0.43) | LMNAHPGDESR1MAPTALDH1A1 | |
| SCHEMBL5471316 | 0.81 | HPGD (0.63) | LMNAHPGDESR1MAPTALDH1A1 | |
| SCHEMBL5471315 | 0.81 | HPGD (0.63) | LMNAHPGDESR1MAPTALDH1A1 | |
| SCHEMBL11236896 | 0.78 | HDAC1 (0.42) | LMNAHPGDESR1MAPTALDH1A1 | |
| SCHEMBL11098296 | 0.78 | HPGD (0.60) | LMNAHPGDESR1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 447 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4724477-A1 | CIRCULARIZED ANTIBODY MOLECULES | Regeneron Pharmaceuticals, Inc. (US) | 2026-04-15 | — | — | EP | claimed |
| US-20260004482-A1 | METHOD, SYSTEM, AND DEVICE FOR ULTRA-LOW-DOSE ORAL CBCT IMAGING | CHINA-JAPAN FRIENDSHIP HOSPITAL (CHINA JAPAN FRIENDSHIP CLINICAL MEDICAL RESEARCH INSTITUTE) (CN) | 2026-01-01 | — | — | US | claimed |
| EP-4213135-B1 | SECURE EXPONENT UNIFICATION SYSTEM, SECURE EXPONENT UNIFICATION APPARATUS, SECURE EXPONENT UNIFICATION METHOD, SECURE SUM COMPUTING SYSTEM, SECURE SUM-OF-PRODUCT COMPUTING SYSTEM, AND PROGRAM | NTT INC (JP) | 2025-12-24 | — | — | EP | claimed |
| EP-4634019-A1 | SYSTEM FOR CONTROLLING BRAKING/TRACTION OF AN ELECTRIC OR HYBRID VEHICLE | Brembo S.p.A. (IT) | 2025-10-22 | — | — | EP | claimed |
| EP-4210028-B1 | SECURE SHIFT SYSTEM, SECURE SHIFT APPARATUS, SECURE SHIFT METHOD, AND PROGRAM | NIPPON TELEGRAPH & TELEPHONE (JP) | 2025-06-11 | — | — | EP | claimed |
| CN-119954766-A | Rosin alkane type diterpenoid compound and extraction method and application thereof | 河北医科大学 | 2025-05-09 | — | — | CN | claimed |
| WO-2025092272-A1 | METHOD, SYSTEM AND APPARATUS FOR ORAL CAVITY CBCT ULTRALOW-DOSE IMAGING | 中日友好医院(中日友好临床医学研究所) | 2025-05-08 | — | — | WO | claimed |
| CN-119696961-A | Channel estimation method, terminal and medium based on meta-learning under ultra-large-scale MIMO | 重庆邮电大学 | 2025-03-25 | — | — | CN | claimed |
| CN-116324934-B | Secret shift system, secret shift device, secret shift method, and recording medium | 日本电信电话株式会社 | 2025-02-25 | — | — | CN | claimed |
| US-20250011449-A1 | CIRCULARIZED ANTIBODY MOLECULES | REGENERON PHARMACEUTICALS, INC. (US) | 2025-01-09 | — | — | US | claimed |
| WO-2022079890-A1 | SECRET SHIFT SYSTEM, SECRET SHIFT DEVICE, SECRET SHIFT METHOD, AND PROGRAM | 日本電信電話株式会社 | 2022-04-21 | — | — | WO | claimed |
| EP-3984543-A1 | USE OF EXTRACT FROM RABBIT SKIN INFLAMED BY VACCINIA VIRUS IN TREATMENT OF CANCER | Mega Winning Limited (HK) | 2022-04-20 | — | — | EP | claimed |
| CN-114236374-A | Real-time diagnosis method for open circuit fault of rectifier | 中国矿业大学 | 2022-03-25 | — | — | CN | claimed |
| WO-2022060993-A1 | SYSTEM AND METHOD FOR INTEGRATED BLOOD VESSEL EMBOLIZATION AND LOCALIZED DRUG DELIVERY | FARHA SAID (US) | 2022-03-24 | — | — | WO | claimed |
| CN-114138543-A | Data strip coding method, system, device and medium | 深信服科技股份有限公司 | 2022-03-04 | — | — | CN | claimed |
| EP-3951419-A1 | APPARATUS COMPRISING AT LEAST ONE PROCESSOR | Nokia Technologies Oy (FI) | 2022-02-09 | — | — | EP | claimed |
| US-4914105-A | NONTOXIC, REDUCED SIDE EFFECTS | FUJII SETSURO (JP) | 1990-04-03 | — | — | US | claimed |
| US-4719213-A | Anti-cancer composition for delivering 5-fluorouracil | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1988-01-12 | — | — | US | claimed |
| US-4371535-A | Method of and composition for delivering 5-fluorouracil to tumors | TAIHO PHARMACEUTICAL COMPANY LIMITED (JP) | 1983-02-01 | — | — | US | claimed |
| US-4249006-A | Method of producing 5-fluorouracil derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1981-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260004482-A1 | METHOD, SYSTEM, AND DEVICE FOR ULTRA-LOW-DOSE ORAL CBCT IMAGING | BECN1, NCDN, OGT | LMNA 3402/4885HPGD 3638/4885ESR1 1503/4885 |
| US-20250011449-A1 | CIRCULARIZED ANTIBODY MOLECULES | IGLV6-57, IGSF11, CD2BP2 | LMNA 4176/4885HPGD 4489/4885ESR1 4056/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.